Immune Checkpoint Inhibitor (Ici) Treatment In Advanced Melanoma (Amel) Patients (Pts) With Renal Or Hepatic Dysfunction (Dysf): Real-World Patient Characteristics And Outcomes.
JOURNAL OF CLINICAL ONCOLOGY(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要